Relationship between hyperuricemia and metabolic syndrome

Alderman, M., Redfern, J.S., 2004. Serum uric acid: a cardiovascular risk factor? Ther. Umsch., 61(9):547–552. [doi: 10.1024/0040-5930.61.9.547]

Becker, M.A., Jolly, M., 2006. Hyperuricemia and associated disease. Rheum. Dis. Clin. North Am., 32(2):275–287. [doi: 10.1016/j.rdc.2006.02.005]

Bedir, A., Topbas, M., Tanyeri, F., Alvur, M., Arik, N., 2003. Leptin might be a regulator of serum uric acid concentration in human. Jpn. Heart J., 44(4):527–536. [doi: 10.1536/jhj.44.527]

Bo, S., Cavallo-Perin, P., Gentile, L., Repetti, E., Pagano, G., 2001. Low HDL cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients. Diabetes Metab., 27(1):31–35.

Bonora, E., Targher, G., Zenere, M.B., Saggiani, F., Cacciatori, V., Tosi, F., Travia, D., Zenti, M.G., Branzi, P., Santi, L., et al., 1996. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int. J. Obes. Relat. Metab. Disord., 20(11):975–980.

Bosello, O., Zamboni, M., 2000. Visceral obesity and metabolic syndrome. Obes. Rev., 1(1):47–56. [doi: 10.1046/j.1467-789x.2000.00008.x]

Conen, D., Wietlisbach, V., Bovet, P., Shamlaye, C., Riesen, W., Paccaud, F., Burnier, M., 2004. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 4(1):9. [doi: 10.1186/1471-2458-4-9]

Feig, D.I., Johnson, R.J., 2003. Hyperuricemia in childhood primary hypertension. Hypertension, 42(3):247–252. [doi: 10.1161/01.HYP.0000085858.66548.59]

Fruehwald-Schultes, B., Peters, A., Kern, W., Beyer, J., Pfutzner, A., 1999. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism, 48(6): 677–680. [doi: 10.1016/S0026-0495(99)90163-4]

Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C.Jr, et al., 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17): 2735–2752. [doi: 10.1161/CIRCULATIONAHA.105.169404]

Himmelmann, A., Kjeldsen, S.E., Hedner, T., 2003. Recent hypertension guidelines: JNC-7 and ESH/ESC. Blood Press., 12(4):196–197. [doi: 10.1080/08037050310015854]

Hochberg, M.C., Smolen, J.S., Weinblatt, M.E., Weisman, M.H., 2003. Rheumatology, 3rd Ed. Mosby, New York.

Krishnan, E., Kwoh, C.K., Schumacher, H.R., Kuller, L., 2007. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension, 49(2): 298–303. [doi: 10.1161/01.HYP.0000254480.64564.b6]

Leyva, F., Wingrove, C.S., Godsland, I.F., Stevenson, J.C., 1998. The glycolytic pathway to coronary heart disease: a hypothesis. Metabolism, 47(6):657–662. [doi. 10.1016/S0026-0495(98)90026-9]

Matsuura, F., Yamashita, S., Nakamura, T., Nishida, M., Nozaki, S., Funahashi, T., Matsuzawa, Y., 1998. Effect of visceral fat accumulation on uric acid metabolismin male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism, 47(8):929–933. [doi: 10.1016/S0026-0495(98)90346-8]

Nakagawa, T., Hu, H., Zharikov, S., Tuttle, K.R., Short, R.A., Glushakova, O., Ouyang, X., Feig, D.I., Block, E.R., Herrera-Acosta, J., et al., 2006. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal Physiol., 290(3):F625–F631. [doi: 10.1152/ajprenal.00140.2005]

Nakanishi, N., Okamoto, M., Yoshida, H., Matsuo, Y., Suzuki, K., Tatara, K., 2003. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur. J. Epidemiol., 18(6):523–530. [doi: 10.1023/A:1024600905574]

Rho, Y.H., Choi, S.J., Lee, Y.H., Ji, J.D., Choi, K.M., Baik, S.H., Chung, S.H., Kim, C.G., Choe, J.Y., Lee, S.W., et al., 2005. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J. Korean Med. Sci., 20(6):1029–1033.

Schachter, M., 2005. Uric acid and hypertension. Curr. Pharm. Des., 11(32):4139–4143. [doi: 10.2174/138161205774913246]

Schmidt, M.I., Watson, R.L., Duncan, B.B., Metcalf, P., Brancati, F.L., Sharrett, A.R., Davis, C.E., Heiss, G., 1996. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism, 45(6):699–706. [doi: 10.1016/S0026-0495(96)90134-1]

Sumino, H., Ichikawa, S., Kanda, T., Nakamura, T., Sakamaki, T., 1999. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet, 354(9179):650. [doi: 10.1016/S0140-6736(99)92381-4]

Tai, E.S., Emmanuel, S.C., Chew, S.K., Tan, B.Y., Tan, C.E., 1999. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes, 48(5):1088–1092. [doi: 10.2337/diabetes.48.5.1088]

Yoo, T.W., Sung, K.C., Shin, H.S., Kim, B.J., Kim, B.S., Kang, J.H., Lee, M.H., Park, J.R., Kim, H., Rhee, E.J., et al., 2005. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ. J., 69(8):928–933. [doi: 10.1253/circj.69.928]